Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Delfi Diagnostics
MedTech
Tempus AI IPO drives $6.6B in VC exit value for medtech sector
Tempus AI’s IPO and Insightec, BillionToOne funding rounds bode well for the medtech sector, according to PitchBook’s Q2 report.
Emma Beavins
Aug 21, 2024 10:21am
Delfi debuts tumor-monitoring test alongside Immunocore collab
Feb 1, 2024 11:31am
Delfi launches blood-based lung cancer screening test
Oct 9, 2023 8:00am
Delfi Diagnostics scoops up $225M for its cancer blood tests
Jul 18, 2022 3:30pm
Fierce Medtech's 2021 Fierce 15
Mar 7, 2022 3:00am
Delfi Diagnostics' blood test spots 90% of cancer cases: study
Aug 20, 2021 10:05am
